1.Peleg, A. Y. and D.C. Hooper, Hospital-acquired infections due to gram-negative bacteria. The New England journal of medicine, 2010. 362(19): p. 1804–1813.
2.Ghasemian, A., et al., Molecular Typing of Klebsiella pneumoniae isolates using Repetitive Extragenic Palindromic Sequence-Based PCR in a Hospital in Tehran, Iran. Int J Enteric Pathog, 2018. 6(1): p. 27–30.
3.ESLAMI, M., et al., IDENTIFICATION OF CTX-M, SHV AND TEM PRODUCING KLEBSIELLA PNEUMONIAE WITH USING OF REP-PCR TYPING ASSAY. 2017.
4.Peerayeh, S. N., et al., High frequency of extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates from male patients’ Urine. Archives of Clinical Infectious Diseases, 2016. 11(2).
5.Peleg, A. Y. and D.C. Hooper, Hospital-acquired infections due to gram-negative bacteria. New England Journal of Medicine, 2010. 362(19): p. 1804–1813.
6.Yigit, H., et al., Novel carbapenem-hydrolyzing β-lactamase, KPC–1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrobial agents and chemotherapy, 2001. 45(4): p. 1151–1161.
7.Naas, T., et al., Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrobial agents and chemotherapy, 2005. 49(10): p. 4423–4424.
8.Najar Peerayeh, S., et al., High prevalence of blaCTX-M–1 group extended-spectrum β-lactamase genes in Escherichia coli isolates from Tehran. Jundishapur Journal of Microbiology, 2013. 6(7): p. 1–6.
9.Bush, K., G. A. Jacoby, and A. A. Medeiros, A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrobial agents and chemotherapy, 1995. 39(6): p. 1211.
10.Eslami, M. and P. S. NAJAR, Phenotypic and molecular detection of TEM, PER, and VEB beta-lactamases in clinical strains of Escherichia coli. 2012.
11.Yong, D., et al., Characterization of a new metallo-β-lactamase gene, blaNDM–1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrobial agents and chemotherapy, 2009. 53(12): p. 5046–5054.
12.Zhao, W.-H. and Z.-Q. Hu, Epidemiology and genetics of VIM-type metallo-β-lactamases in Gram-negative bacilli. Future microbiology, 2011. 6(3): p. 317–333.
13.Safari, M., et al., High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. Journal of research in health sciences, 2013. 13(2): p. 162–167.
14.Rezai, M. S., et al., Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in North of Iran. BioMed research international, 2015. 2015.
15.Jamal, W. Y., M. J. Albert, and V. O. Rotimi, High prevalence of new delhi metallo-β-lactamase–1 (NDM–1) producers among carbapenem-resistant Enterobacteriaceae in Kuwait. PloS one, 2016. 11(3): p. e0152638.
16.Sugumar, M., et al., Detection of OXA–1 β-lactamase gene of Klebsiella pneumoniae from blood stream infections (BSI) by conventional PCR and in-silico analysis to understand the mechanism of OXA mediated resistance. PloS one, 2014. 9(3): p. e91800.
17.Coque, T., F. Baquero, and R. Canton, Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveillance, 2008. 13(47): p. 19044.
18.Villegas, M., et al., Prevalence of extended-spectrum β-lactamases in South America. Clinical Microbiology and Infection, 2008. 14: p. 154–158.
19.Canton, R., et al., Prevalence and spread of extended‐spectrum β‐lactamase‐producing Enterobacteriaceae in Europe. Clinical Microbiology and infection, 2008. 14: p. 144–153.